In last trading session, AdaptHealth Corp (NASDAQ:AHCO) saw 1.32 million shares changing hands with its beta currently measuring 1.72. Company’s recent per share price level of $7.73 trading at $0.28 or 3.83% at ring of the bell on the day assigns it a market valuation of $1.04B. That closing price of AHCO’s stock is at a discount of -53.95% from its 52-week high price of $11.90 and is indicating a premium of 8.02% from its 52-week low price of $7.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.72 million shares which gives us an average trading volume of 1.66 million if we extend that period to 3-months.
For AdaptHealth Corp (AHCO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.78. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.04 in the current quarter.
AdaptHealth Corp (NASDAQ:AHCO) trade information
Upright in the green during last session for gaining 3.83%, in the last five days AHCO remained trading in the red while hitting it’s week-highest on Wednesday, 04/16/25 when the stock touched $7.73 price level, adding 5.27% to its value on the day. AdaptHealth Corp’s shares saw a change of -18.80% in year-to-date performance and have moved -3.37% in past 5-day. AdaptHealth Corp (NASDAQ:AHCO) showed a performance of -25.60% in past 30-days. Number of shares sold short was 8.42 million shares which calculate 4.6 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 13 to the stock, which implies a rise of 40.54% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -55.24% in reaching the projected high whereas dropping to the targeted low would mean a loss of -55.24% for stock’s current value.
AdaptHealth Corp (AHCO) estimates and forecasts
This year revenue growth is estimated to rise 0.21% from the last financial year’s standing.
8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 764.77M for the same. And 8 analysts are in estimates of company making revenue of 808.16M in the next quarter. Company posted 792.5M and 805.98M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 0.14% while estimates for its earnings growth in next 5 years are of 12.74%.
AdaptHealth Corp (NASDAQ:AHCO)’s Major holders
Insiders are in possession of 11.90% of company’s total shares while institution are holding 101.90 percent of that, with stock having share float percentage of 115.66%. Investors also watch the number of corporate investors in a company very closely, which is 101.90% institutions for AdaptHealth Corp that are currently holding shares of the company. OEP CAPITAL ADVISORS, L.P. is the top institutional holder at AHCO for having 13.82 million shares of worth $138.18 million. And as of 2024-06-30, it was holding 10.3726 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 13.58 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.1904 of outstanding shares, having a total worth of $135.75 million.
On the other hand, Pacer Funds Trust-Pacer US Small Cap Cash Cows ETF and iShares Trust-iShares Core S&P Small-Cap ETF are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 7.56 shares of worth $58.45 million or 5.61% of the total outstanding shares. The later fund manager was in possession of 6.57 shares on Mar 31, 2025 , making its stake of worth around $50.77 million in the company or a holder of 4.87% of company’s stock.